# HYDRALAZINE HYDROCHLORIDE

NDC: 51655-305
Generic name: hydralazine hydrochloride
Labeler / Manufacturer: Northwind Health Company, LLC
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: TABLET, FILM COATED
Routes: ORAL
Marketing started: 20200520
Marketing ended: 20260831
FDA application: ANDA086242

## Active ingredients

- HYDRALAZINE HYDROCHLORIDE: 25 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"51655-305"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=51655-305
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=ab1c6f37-3b64-23fb-e053-2995a90a932f